With support from Arnold Ventures, the National Academy for State Health Policy (NASHP) is expanding its capacity to help states lower the trajectory of their health care spending through its new Center for State Health Care System Costs. Modeled on the work of its Prescription Drug Pricing Center, this new center will address health system […]
Author Archive for: trish-riley
About Trish Riley
Trish Riley is executive director of the National Academy for State Health Policy (NASHP) and president of its corporate board. She helped build NASHP as CEO from 1988 to 2003.
Previously, she was a senior fellow in State Health Policy at George Washington University and at the Muskie School of Public Service, University of Southern Maine. From 2003 to 2011, she served as director of the Maine Governor’s Office of Health Policy and Finance, leading Maine’s effort to develop a comprehensive, coordinated state health system that included increasing access to affordable health insurance. She was the principal architect of Dirigo Health Reform and served as Maine’s liaison to the federal government and Congress, particularly during deliberations around national health reform. She chaired the Governor’s Steering Committee to develop a plan to implement the Affordable Care Act in Maine.
Riley has also held appointed positions under five Maine governors, directing the Office on Aging, Medicaid and state health agencies, and health planning and licensing programs.
Riley has published and presented widely about state health reform. She served as a member of the Kaiser Commission on Medicaid and the Uninsured, the Medicaid and CHIP Payment and Access Commission (MACPAC), the Health Services Committee of the Institute of Medicine, the National Academy for Social Insurance, and the board of directors of Maine’s co-op insurance plan. She was a member of the Institute of Medicine’s Subcommittee on Creating an External Environment for Quality. She also previously served as a member of the board of directors of the National Committee on Quality Assurance. Riley holds a BS and MS from the University of Maine.
Entries by Trish Riley
The same drugs that appear on state transparency reports identifying costly drugs also appear in an independent research institute’s report on drugs whose rapidly rising prices were not supported by new clinical evidence on the drugs’ safety or efficacy. The Institute for Clinical and Economic Review (ICER), an independent research organization that objectively evaluates prescription […]
States are incrementalists – enacting laws, amending them, and building on their successes – and that strategy is clearly visible in Massachusetts Gov. Charlie Baker’s bold and comprehensive legislative proposal, An Act to Improve Health Care by Investing in VALUE, announced last week. Baker’s proposal calls on payers and providers to increase expenditures on primary […]
State-based marketplace (SBM) leaders convened in Washington, DC last week to share experiences and ideas and meet with key Congressional staff in advance of this year’s open enrollment period. SBMs, which exercise total control over their health insurance marketplaces in contrast to states that use the federal marketplace, are making considerable progress in reaching and […]
Every state in the nation has proposed bills to limit pharmaceutical drug prices and the pace of that legislative work increases each year. The usual responses from pharmaceutical manufacturers and their allies is to threaten to reduce their investments in new drug research and development and challenge the new state laws in federal court. In […]
To address America’s drug pricing problem, state policymakers face myriad conflicts and trade-offs, inadequate information about the “black box” of drug pricing, and an uncertain road map for how best to address the issue. This NASHP guest report, published in the September 2019 edition of the Journal of Legal Medicine, provides an overview of challenges states face […]
The 32nd National Academy’s State Health Policy (NASHP) conference, held last week in Chicago, was a blockbuster from start to finish and the largest one in NASHP’s history. The conference opened as treacherous thunderstorms rolled across the Midwest causing untold flight delays and one emergency landing. Many attendees, NASHP staff, and speakers were delayed and worked […]
With support from Arnold Ventures, the National Academy for State Health Policy (NASHP) is expanding its capacity to help states address health care costs by establishing a Health Care Cost Hub with two divisions. One division continues the work of the Center for State Rx Drug Pricing, and the new division – the Center for […]
The Trump Administration’s Safe Importation Action Plan lays out two pathways to support importation of lower-cost prescription drugs, but raises questions that need responses. In Pathway 1, the Administration gives a nod to state efforts to create wholesale importation programs for certain high-cost drugs, mirroring the provisions of current state efforts and federal requirements. That’s […]